Response to: Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutations.
Fabrizio CitarellaMarco RussanoGiuseppe PerroneBruno VincenziGiuseppe ToniniDaniele SantiniPublished in: Thoracic cancer (2021)